Acceder

Publicaciones - CARDIOLOGIA CLINICA Y EXPERIMENTAL

Cargando...
Kaski JP, Norrish G, Gimeno Blanes JR, Charron P, Elliott P, Tavazzi L, Tendera M, Laroche C, Maggioni AP, Baban A, Khraiche D, Ziolkowska L, Limongelli G, Ojala T, Gorenflo M, Anastasakis A, Mostafa S, Caforio ALP; EORP Paediatric Cardiomyopathy Registry Investigators. Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry. Eur Heart J. 2024 Apr 21;45(16):1443-1454. doi: 10.1093/eurheartj/ehae109. PubMed PMID: 38427064.
AÑO: 2024; IF: 39.3
Pastor-Perez FJ, Garrido-Bravo IP, Penafiel-Verdu P, Fernandez-Villa N, Manzano-Fernandez S, Oliva-Sandoval MJ, Perez-Martinez MT, Caro-Martinez C, Hernandez-Vicente A, Pascual-Figal DA; en nombre de los investigadores del estudio REMOVE. Withdrawal of drug therapy in responders to cardiac resynchronization therapy: rationale and design of the REMOVE trial. Rev Esp Cardiol (Engl Ed). 2024 May 1:S1885-5857(24)00143-9. doi: 10.1016/j.rec.2024.02.021. Online ahead of print. English, Spanish. PubMed PMID: 38701881.
AÑO: 2024; IF: 5.9
Pascual-Figal D, Nunez Villota J, Perez-Martinez MT, Gonzalez-Juanatey JR, Taibo-Urquia M, Llacer Iborra P, Gonzalez-Martin J, Villar S, Soler M, Mirabet S, Aimo A, Riquelme-Perez A, Anguita Sanchez M, Martinez-Selles M, Sanchez PL, Ibanez B, Bayes-Genis A; on behalf of the COLICA Investigators (see Appendix). Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA). Eur J Heart Fail. 2024 Jun 4. doi: 10.1002/ejhf.3300. Online ahead of print. PubMed PMID: 38837516.
AÑO: 2024; IF: 18.2
Anguita-Gamez M, Vivas D, Ferrandis R, Esteve-Pastor MA, Marin F, Anguita Sanchez M; en representacion de los investigadores del estudio REQXAA. Periprocedural use of antithrombotic therapy in interventional cardiology in Spain: are we doing better than other specialties? Rev Esp Cardiol (Engl Ed). 2024 Apr 3:S1885-5857(24)00108-7. doi: 10.1016/j.rec.2024.02.017. Online ahead of print. No abstract available. English, Spanish. PubMed PMID: 38580142.
AÑO: 2024; IF: 5.9
Sabater Molina M, Gimeno Blanes JR. In recognition of the Spanish origin of CRISPR/Cas9. Implications for the treatment of familial heart disease. Rev Esp Cardiol (Engl Ed). 2024 Feb 19:S1885-5857(24)00057-4. doi: 10.1016/j.rec.2024.01.007. Online ahead of print. No abstract available. English, Spanish. PubMed PMID: 38382800.
AÑO: 2024; IF: 5.9
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII